Christopher Leamon

Christopher Leamon

Directeur Technique/Scientifique/R&D chez FUSN PHAR
59 ans
Health Technology
Consumer Services
Commercial Services

Profil

Christopher P.
Leamon
is Chief Scientific Officer at Fusion Pharmaceuticals, Inc. since 2021.
Formerly, Dr. Leamon was Executive Director-Radioligand Drug Discovery at Novartis Institutes for Biomedical Research, Inc., Principal at Glaxo Wellcome Plc, Vice President-Research at Endocyte, Inc. from 1999 to 2011, and Vice President-Discovery Research at Advanced Accelerator Applications USA, Inc. Education includes undergraduate studies at Baldwin-Wallace College and a doctorate from Purdue University.

Postes actifs de Christopher Leamon

SociétésPosteDébut
FUSN PHAR Directeur Technique/Scientifique/R&D 02/11/2021

Anciens postes connus de Christopher Leamon

SociétésPosteFin
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
ENDOCYTE, INC. Directeur Technique/Scientifique/R&D -
Voir l'expérience en détail de Christopher Leamon

Formation de Christopher Leamon

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

27

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Christopher Leamon
🔇